The Biogenic Eye

12
THE BIOGENIC EYE Mike DeSalvio, Michael Nguyen, Khine Win, Kevin Ip, John Chi

description

Mike DeSalvio, Michael Nguyen, Khine Win, Kevin Ip , John Chi. The Biogenic Eye. Who. Patients suffering from non-preventable blindness in one eye Not designed for completely blind Must currently retain the original eye to prevent muscle atrophy for attachment - PowerPoint PPT Presentation

Transcript of The Biogenic Eye

Page 1: The Biogenic Eye

THE BIOGENIC EYE

Mike DeSalvio, Michael Nguyen,Khine Win, Kevin Ip, John Chi

Page 2: The Biogenic Eye

Who Patients suffering from non-preventable blindness in

one eyeNot designed for completely blindMust currently retain the original eye to prevent muscle

atrophy for attachmentScreened for compatibility with blood thinners

In 2002 roughly 161 million visually impaired world wide. (W.H.O.)Of this 124 million had low visionAnd 37 million are blindChildhood blindness in 2002 reached 3.9%47% caused by cataracts

Michael N

Page 3: The Biogenic Eye

What Bionic prosthetic camera mounted within

a silicon based plastic casing Contains an internal reservoir with a

lacrimating compound for lubrication Signal Processor Radio antenna Muscular attachments

Michael N

Page 4: The Biogenic Eye

Where Mounted within the eye socket of the

affected individual Corresponding hardware is “installed”

near the occipital lobe near brain stem Utilizing current patent WO/1999/045870

Delivery reservoir modification Negotiate a non-exclusive licensing agreement with Johns

Hopkins University for the current technology

http://www.wipo.int/pctdb/en/wo.jsp?WO=1999045870John

Page 5: The Biogenic Eye

Why Only 3.9% of children are born blind or

developed blindness. Permanent loss of sight

Most adults loose sight because of Cataracts (48%) and Glaucoma (12%)

Macular degeneration, corneal opacity, and diabetes <10%

John

Page 6: The Biogenic Eye

Why Provide a prosthetic alternative to

clinical blindness to improve quality of life.

Allow for more mobilityAble to driveDepth perceptionNight vision (not like night vision goggles)

Kevin

Page 7: The Biogenic Eye

When Total development time is 5 years

Engineering timeIn vivo testing

By using an existing patent, development time is significantly shorter~1- 2 years

Kevin

Page 8: The Biogenic Eye

How The device works by transmitting a

visual image from a camera into a processor and through the optic nerve.

Khine

Page 9: The Biogenic Eye

Quality Function Deployment

QFD AnalysisX's (How's)

Y's (What's)

Joining optic nerve and

surgical implant

Low and High lux & resolution for better

viewing in color

High quality

Polymer and

lactimating

resevoir

Muscular attachme

nt and freedom

of moveme

ntIris color

options

prescription lens

ready

Pendulum

Charging 0 0 Total

Function 5 H H   H     H     180Performance 4 H M H H   L H     160Comfort 3   M H L L   L     45Practicality 2 L L M M H H H     70Style 1       L H H       19                    0Total 83 68 69 91 30 31 102 0 0 474Relative Weight (Priority) 17.51% 14.35% 14.56% 19.20% 6.33% 6.54% 21.52% 0.00% 0.00% 

Mike D

Page 10: The Biogenic Eye

Analysis Highest preference was performance

and lowest preference was style Ability to see in darker atmospheres

significantly outweighed alternatives Iris color was the least concerned

benefit, correlating to the customer preference

Mike D

Page 11: The Biogenic Eye

Expanded QFD See Document…

Mike D

Page 12: The Biogenic Eye

Questions